pulmonary diseases

175
Pulmonary Diseases

Upload: tawny

Post on 06-Jan-2016

31 views

Category:

Documents


2 download

DESCRIPTION

Pulmonary Diseases. Pulmonary Diseases & Disorders. Pulmonary Disease & Conditions may result from: Infectious causes Non-Infectious causes Adversely affect one or more of the following Ventilation Diffusion Perfusion. Pulmonary Diseases & Disorders. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Pulmonary Diseases

Pulmonary DiseasesPulmonary Diseases

Page 2: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders

Pulmonary Disease & Conditions may result from:– Infectious causes– Non-Infectious causes

Adversely affect one or more of the following– Ventilation– Diffusion– Perfusion

Page 3: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders The Respiratory Emergency may stem from

dysfunction or disease of (examples only):– Control System

• Hyperventilation• Central Respiratory Depression• CVA

– Thoracic Bellows• Chest/Diaphragm Trauma• Pickwickian Syndrome• Guillian-Barre Syndrome• Myasthenia Gravis• COPD

Page 4: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders The Respiratory Emergency may affect the

upper or lower airways

Upper Airway Obstruction– Tongue– Foreign Body Aspiration– Angioneurotic Edema– Maxillofacial, Larnygotracheal Trauma– Croup– Epiglottitis

Page 5: Pulmonary Diseases

Respiratory Emergencies: CausesRespiratory Emergencies: Causes

Lower Airway Obstruction– Emphysema– Chronic Bronchitis– Asthma– Cystic Fibrosis

Page 6: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders

The Respiratory Emergency may stem from Gas Exchange Surface Abnormalities– Cardiogenic Pulmonary Edema– Non-cardiogenic Pulmonary Edema– Pneumonia– Toxic Gas Inhalation– Pulmonary Embolism– Drowning

Page 7: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders

Problems with the Gas

Exchange Surface

Page 8: Pulmonary Diseases

Pulmonary EdemaPulmonary Edema

Page 9: Pulmonary Diseases

Pulmonary Edema: PathophysiologyPulmonary Edema: Pathophysiology

A pathophysiologic condition, not a disease– Fluid in and around alveoli– Interferes with gas exchange– Increases work of breathing

Two Types– Cardiogenic (high pressure)– Non-Cardiogenic (high permeability)

Page 10: Pulmonary Diseases

Pulmonary EdemaPulmonary Edema High Pressure (cardiogenic)

• AMI• Chronic HTN• Myocarditis

High Permeability (non-cardiogenic)• Poor perfusion, Shock, Hypoxemia• High Altitude, Drowning• Inhalation of pulmonary irritants

Page 11: Pulmonary Diseases

Cardiogenic Pulmonary Edema: EtiologyCardiogenic Pulmonary Edema: Etiology

Left ventricular failure Valvular heart disease

– Stenosis– Insufficiency

Hypertensive crisis (high afterload) Volume overload

Increased Pressure in Pulmonary Vascular Bed

Page 12: Pulmonary Diseases

Pulmonary EdemaPulmonary Edema

High Permeability– Disrupted alveolar-capillary membrane– Membrane allows fluid to leak into the interstitial

space– Widened interstitial space impairs diffusion

Page 13: Pulmonary Diseases

Non-Cardiogenic Pulmonary Edema: EtiologyNon-Cardiogenic Pulmonary Edema: Etiology

Toxic inhalation Near drowning Liver disease Nutritional deficiencies Lymphomas High altitude pulmonary edema Adult respiratory distress syndrome

Increased Permeability of Alveolar-Capillary Walls

Page 14: Pulmonary Diseases

Pulmonary Edema: Signs &SymptomsPulmonary Edema: Signs &Symptoms

Dyspnea on exertion Paroxysmal nocturnal dyspnea Orthopnea Noisy, labored breathing Restlessness, anxiety Productive cough (frothy sputum) Rales, wheezing Tachypnea Tachycardia

Page 15: Pulmonary Diseases

Management of Non-Cardiogenic Pulmonary EdemaManagement of Non-Cardiogenic Pulmonary Edema Position Oxygen PPV / Intubation

– CPAP– PEEP

IV Access; Minimal fluid administration Treat the underlying cause

– Diuretics usually not helpful; May be harmful Transport

Page 16: Pulmonary Diseases

Adult Respiratory Distress SyndromeAdult Respiratory Distress Syndrome

AKA: Non-cardiogenic pulmonary edema A complication of:

– Severe Trauma / Shock– Severe infection / Sepsis– Bypass Surgery– Multiple blood transfusions– Drug overdose– Aspiration– Decreased compliance– Hypoxemia

Page 17: Pulmonary Diseases

Pneumonia Pneumonia

Page 18: Pulmonary Diseases

PneumoniaPneumonia

Fifth leading cause of death in US/Canada Group of Specific infections Risk factors

– Cigarette smoking– Exposure to cold– Extremes of age

• young • old

Page 19: Pulmonary Diseases

PneumoniaPneumonia Inflammation of the bronchioles and alveoli

– Products of inflammation (secretions, pus) add to respiration difficulty

Gas exchange is impaired Work of breathing increases May lead to

– Atelectasis– Sepsis– VQ Mismatch– Hypoxemia

Page 20: Pulmonary Diseases

Pneumonia: EtiologyPneumonia: Etiology

Viral Bacterial Fungi Protozoa (pneumocystis) Aspiration

Page 21: Pulmonary Diseases

Presentation of PneumoniaPresentation of Pneumonia

Shortness of breath, Dyspnea Fever, chills Pleuritic Chest Pain, Tachycardia Cough

– Green/brown sputum May have crackles, rhonchi or wheezing in

peripheral lung fields– Consolidation– Egophony

Page 22: Pulmonary Diseases

Management of PneumoniaManagement of Pneumonia

Treatment mostly based upon symptoms– Oxygen– Rarely is intubation required– IV Access & Rehydration

– B2 agonists may be useful

– Antibiotics (e.g. Rocephin)– Antipyretics

Page 23: Pulmonary Diseases

Pneumonia: ManagementPneumonia: Management

MD follow-up for labs, cultures & Rx Transport considerations

– Elderly have significant co-morbidity– Young have difficulty with oral medications– ED vs PMD office/clinic– Transport in position of comfort

Would an anticholinergic like Atrovent be useful in managing

pneumonia?

Page 24: Pulmonary Diseases

Pulmonary EmbolismPulmonary Embolism

Page 25: Pulmonary Diseases

Pulmonary EmbolismPulmonary Embolism

~ 50,000 deaths / year/ US– ~5% of all sudden deaths– <10% of all PE result in death

Page 26: Pulmonary Diseases

Pulmonary Embolism: PathophysiologyPulmonary Embolism: Pathophysiology

Something moving with flow of blood passes through right heart into pulmonary circulation

It reaches an area too narrow to pass through and lodges there

Part of pulmonary circulation is blocked Blood:

– Does not pass alveoli– Does not exchange gases

Page 27: Pulmonary Diseases

Pulmonary Embolism (PE)Pulmonary Embolism (PE)

A disorder of perfusion Combination of factors increase probability of

occurrence– Hypercoagulability– Platelet aggregation– Deep vein stasis

Embolus usually originates in lower extremities or pelvis

Page 28: Pulmonary Diseases

Pulmonary Embolism (PE)Pulmonary Embolism (PE)

Risk factors– Venostasis or DVT– Recent surgery or trauma

• Long bone fractures (lower)

– Oral contraceptives– Pregnancy– Smoking– Cancer

Page 29: Pulmonary Diseases

Pulmonary Embolism: EtiologyPulmonary Embolism: Etiology

Most Common Cause = Blood Clots

Vessel Wall Injury

Hypercoagulability Venous Stasis

Virchow’sTriad

Page 30: Pulmonary Diseases

Other causes– Air– Amniotic fluid– Fat particles (long bone fracture)– Particulates from substance abuse– Venous catheter

Pulmonary Embolism: EtiologyPulmonary Embolism: Etiology

Page 31: Pulmonary Diseases

Pulmonary Embolism: Signs & SymptomsPulmonary Embolism: Signs & Symptoms

Small Emboli– Rapid Onset– Dyspnea– Tachycardia– Tachypnea– Fever– Episodic = Showers– Evidence or history of thrombophlebitis– Consider early when no other cardiorespiratory

diagnosis fits

Page 32: Pulmonary Diseases

Larger Emboli– Small Emboli S/S plus:– Pleuritic pain– Pleural rub– Coughing– Wheezing– Hemoptysis (rare)

Pulmonary Embolism: Signs & SymptomsPulmonary Embolism: Signs & Symptoms

Page 33: Pulmonary Diseases

Very Large Emboli– Preceded by S/S of Small & Larger Emboli plus: – Central chest pain– Distended neck veins– Acute right heart failure– Shock– Cardiac arrest

Pulmonary Embolism: Signs & SymptomsPulmonary Embolism: Signs & Symptoms

Page 34: Pulmonary Diseases

Pulmonary Embolism: Signs & SymptomsPulmonary Embolism: Signs & Symptoms

There are NO assessment

findings specific to pulmonary embolism

Page 35: Pulmonary Diseases

Management based on severity of Sx/Sx Airway & Breathing

– High concentration O2

– Consider assisting ventilations– Early Intubation

Circulation– IV, 2 lg bore sites

• Fluid bolus then TKO; Titrate to BP ~ 90 mm Hg

– Monitor ECG Rapid transport

Pulmonary Embolism: ManagementPulmonary Embolism: Management

Page 36: Pulmonary Diseases

PE ManagementPE Management Thrombolytics

– Aspirin & Heparin (questionable if any benefit) Rapid transport to appropriate facility

– Embolectomy or thrombolytics at hospital (rarely effective in severe cases due to time delay)

– Poor prognosis when cardiac arrest follows

Page 37: Pulmonary Diseases

Pulmonary EmbolismPulmonary Embolism

If the patient is alive when you get to them, that embolus isn’t going to

kill them.

But the next one they throw might!

Page 38: Pulmonary Diseases

PleurisyPleurisy

Inflammation of pleura caused by a friction rub– layers of pleura rubbing together

Commonly associated with other respiratory disease

Page 39: Pulmonary Diseases

Presentation of PleurisyPresentation of Pleurisy

Sharp, sudden and intermittent chest pain with related dyspnea– Possibly referred to shoulder– May or with respiration

Pleural “friction rub” may be audible” May have effusion or be dry

Page 40: Pulmonary Diseases

PleurisyPleurisy

Management– Based upon severity of presentation– Mostly supportive

Page 41: Pulmonary Diseases

Pulmonary Diseases & DisordersPulmonary Diseases & Disorders

Problems with Airway Obstructions

Page 42: Pulmonary Diseases

Obstructive Airway Diseases

Page 43: Pulmonary Diseases

Obstructive Airway DiseaseObstructive Airway Disease

Asthma Emphysema Chronic Bronchitis

Page 44: Pulmonary Diseases

Obstructive Airway DiseasesObstructive Airway Diseases

Asthma experienced by ~ 4 - 5 % of Canadian population– Mortality rate increasing

Factors leading to Obstructive Airway Diseases– Smoking– Exposure to environmental agents– Genetic predisposition

How does this differ from “COPD”?

Page 45: Pulmonary Diseases

Obstructive Airway DiseaseObstructive Airway Disease

Exacerbation Factors– Intrinsic

• Stress (especially in adults)• URI• Exercise

– Extrinsic• Cigarette Smoke• Allergens• Drugs• Occupational hazards

Page 46: Pulmonary Diseases

Obstructive Airway DiseaseObstructive Airway Disease

General Pathophysiology– Specific pathophysiology varies by disease– Obstruction in bronchioles

• Smooth muscle spasm (beta)• Mucous accumulation• Inflammation

– Obstruction may be reversible or irreversible

Page 47: Pulmonary Diseases

Obstructive Airway DiseaseObstructive Airway Disease

General Pathophysiology– Obstruction results in air trapping

• Bronchioles usually dilate on inspiration• Dilation allows air to enter even in presence of

“obstruction”• Bronchioles tend to constrict on expiration• Air becomes trapped distal to obstruction

Page 48: Pulmonary Diseases

Lower Airway Disease

Page 49: Pulmonary Diseases

Chronic Obstructive Pulmonary Disease

Emphysema

Chronic Bronchitis

(Rarely Asthma may result in COPD)

Page 50: Pulmonary Diseases

COPD: EpidemiologyCOPD: Epidemiology

Most common chronic lung disease 4th leading cause of death many deaths annually

Page 51: Pulmonary Diseases

Emphysema

Type A COPD

Page 52: Pulmonary Diseases

Emphysema: Definition Emphysema: Definition

Destruction of alveolar walls

Distention of pulmonary air spaces

Loss of elastic recoil Destruction of gas

exchange surface

Page 53: Pulmonary Diseases

Emphysema: IncidenceEmphysema: Incidence

Male > females Urban area > rural areas Age usually > 55

Page 54: Pulmonary Diseases

Emphysema:EtiologyEmphysema:Etiology Smoking

– 90% of all cases– Smokers 10x more likely to die of COPD than

non-smokers Environmental factors Alpha – 1 antitrypsin deficiency

– hereditary– 50,000 to 100,000 cases– mostly people of northern European descent

Page 55: Pulmonary Diseases

Emphysema: PathophysiologyEmphysema: Pathophysiology

Decreased surface area leads to decreased gas exchange with blood

Loss of pulmonary capillaries & hypercapnia lead to – increased resistance to blood flow which leads to

• pulmonary HTN• right heart failure (cor pulmonale)

Page 56: Pulmonary Diseases

Emphysema: PathophysiologyEmphysema: Pathophysiology

Loss of elastic recoil leads to increased residual volume and CO2 retention– Air Trapping– Hyperinflation– Hypercapnia -> pulmonary vasoconstriction ->

V/Q mismatch

Page 57: Pulmonary Diseases

Emphysema: Signs and SymptomsEmphysema: Signs and Symptoms

Increasing dyspnea on exertion Non-productive cough Malaise Anorexia, Loss of weight Hypertrophied respiratory accessory muscles

Page 58: Pulmonary Diseases

Emphysema: Signs and SymptomsEmphysema: Signs and Symptoms

Increased Thoracic AP Diameter (Barrel Chest)

Decreased lung/heart sounds

Hyperresonant chest

Page 59: Pulmonary Diseases

Emphysema: Signs and SymptomsEmphysema: Signs and Symptoms Lip pursing on exhalation Clubbed fingertips Altered blood gases

– Normal or decreased PaO2

– Elevated CO2

Cyanosis occurs LATE in course of disease

PINK PUFFER

Page 60: Pulmonary Diseases

Chronic Bronchitis

Type B COPD

Page 61: Pulmonary Diseases

Chronic Bronchitis: DefinitionChronic Bronchitis: Definition

Increased mucus production for > 3 months for > 2 consecutive years

Recurrent productive cough

Page 62: Pulmonary Diseases

Chronic Bronchitis: IncidenceChronic Bronchitis: Incidence

Males > females Urban areas > rural areas Age usually > 45

Page 63: Pulmonary Diseases

Chronic Bronchitis: EtiologyChronic Bronchitis: Etiology

Smoking Environmental irritants

Page 64: Pulmonary Diseases

Chronic Bronchitis: PathophysiologyChronic Bronchitis: Pathophysiology

Mucus plugging/inflammatory edema Increased airflow resistance leads to

alveolar hypoventilation Alveolar hypoventilation leads to

– hypercarbia– hypoxemia

Page 65: Pulmonary Diseases

Chronic Bronchitis: PathophysiologyChronic Bronchitis: Pathophysiology

Hypoxemia leads to– increased RBC’s w/o oxygen which leads to

• cyanosis

Hypercarbia leads to– pulmonary vascular constriction which leads to

• increased right ventricular work which leads to• right heart failure which may progress to• cor pulmonale

Page 66: Pulmonary Diseases

Chronic Bronchitis: Signs and SymptomsChronic Bronchitis: Signs and Symptoms Increasing dyspnea on exertion Frequent colds of increasing duration Productive cough Weight gain, edema (right heart failure) Rales, rhonchi, wheezing Bluish-red skin color (polycythemia) Headache, drowsiness (increased CO2)

Page 67: Pulmonary Diseases

Chronic Bronchitis: Signs and SymptomsChronic Bronchitis: Signs and Symptoms Decreased intellectual ability Personality changes Abnormal blood gases

– Hypercarbia– Hypoxia

Cyanosis EARLY in course of disease

BLUE BLOATER

Page 68: Pulmonary Diseases

COPD Assessment FindingsCOPD Assessment Findings

Chronic condition acute episode S&S of work of breathing and/or hypoxemia

– Use of accessory muscles– Increased expiratory effort– Tachycardia, AMS, Cyanosis– Wheezing, Rhonchi, LS– Thin, red/pink appearance

Saturation usually normal in emphysema

Page 69: Pulmonary Diseases

COPD: ManagementCOPD: Management

Causes of Decompensation– Respiratory infection (increased mucus

production)– Chest trauma (pain discourages coughing or deep

breathing)– Sedation (depression of respirations and

coughing)– Spontaneous pneumothorax– Dehydration (causes mucus to dry out)

Page 70: Pulmonary Diseases

COPD: ManagementCOPD: Management

Airway and Breathing– Sitting position or position of comfort– Calm & Reassure– Encourage cough– Avoid exertion

Oxygen– Don’t withhold

– Maintain O2 saturation above 90 %

TRUE HYPOXIC DRIVE IS VERY RARE

Page 71: Pulmonary Diseases

COPD: ManagementCOPD: Management

Ventilation– Avoid intubation unless absolutely necessary

• near respiratory failure• exhaustion

Circulation– IV TKO– Titrate fluid to degree of dehydration

• 250 cc trial bolus

– Excessive fluid may precipitate CHF– Monitor ECG

Page 72: Pulmonary Diseases

COPD: ManagementCOPD: Management

Drug Therapy– Obtain thorough medication history– Nebulized Beta 2 agonists

• Albuterol• Terbutaline• Metaproterenol• Isoetharine

Page 73: Pulmonary Diseases

COPD: Management

REMEMBER

All bronchodilators are potentially arrhythmogenic

Page 74: Pulmonary Diseases

COPD: ManagementCOPD: Management

Drug Therapy– Ipratropium (anticholinergic) by SVN– (beta-2 agonist) by MDI, SQ or IV– Corticosteroids (anti-inflammatory agent) by IV

Page 75: Pulmonary Diseases

COPD: ManagementCOPD: Management

Avoid– Sedatives

• Restlessness = hypoxia– Antihistamines

• Dry secretions, decrease LOC– Epinephrine

• Myocardial ischemia, arrhythmias– Intubation

• difficult to wean off ventilator

Page 76: Pulmonary Diseases

Reversible Obstructive Airway Disease

Asthma

Page 77: Pulmonary Diseases

Asthma: DefinitionAsthma: Definition

Lower airway hyper-responsiveness to a variety of stimuli

Diffuse reversible airway obstruction or narrowing

Airway inflammation

Page 78: Pulmonary Diseases

Asthma: IncidenceAsthma: Incidence

50% onset before age 10 33% before age 30 “Asthma” in older patients suggests other

obstructive pulmonary diseases Risk Factors

– Family history of asthma– Perinatal exposure to airborne allergens and

irritants– Genetic hypersensitivity to environmental allergens

(Atopy)

Page 79: Pulmonary Diseases

AsthmaAsthma

Diagnosis

– H&P, Spirometry– Hx or presence of episodic symptoms of

airflow obstruction– airflow obstruction is at least partially

reversible– alternative diagnoses are excluded

Page 80: Pulmonary Diseases

AsthmaAsthma

Commonly misdiagnosed in children as– Chronic bronchitis– Recurrent croup– Recurrent URI– Recurrent pneumonia

Page 81: Pulmonary Diseases

AsthmaAsthma

Often triggered by:– Cold temperature– Respiratory Infections– Vigorous exercise– Emotional Stress– Environmental allergens or irritants

Exacerbation– Extrinsic common in children– Intrinsic common in adults

Page 82: Pulmonary Diseases

Asthma PathophysiologyAsthma Pathophysiology

Asthma triggered Bronchial smooth muscle contraction Increased mucus production

– Bronchial ‘plugging’– Relative dehydration

Alveolar hypoventilation – Ventilation Perfusion Mismatch

– CO2 retention

– Air ‘Trapping’

Page 83: Pulmonary Diseases

Asthma: PathophysiologyAsthma: Pathophysiology

Bronchospasm

Bronchial Edema Increased MucusProduction

Page 84: Pulmonary Diseases

Asthma: PathophysiologyAsthma: Pathophysiology

Page 85: Pulmonary Diseases

Asthma: PathophysiologyAsthma: Pathophysiology

Cast of airway produced by asthmatic mucus plugs

Page 86: Pulmonary Diseases

Asthma: PathophysiologyAsthma: Pathophysiology

Difficulty exhaling– chest hyperinflation

Poor gas exchange– hypoxia– hypercarbia

Increased respiratory water loss– dehydration

Page 87: Pulmonary Diseases

Asthma: TypesAsthma: Types

Type 1 Extrinsic– Classic allergic asthma– Common in children, young adults– Seasonal in nature– Sudden brief attacks– Major component is bronchospasm– Good bronchodilator response

Page 88: Pulmonary Diseases

Asthma: TypesAsthma: Types

Type 2 Extrinsic Asthma– Adults < 35– Long term exposure to irritants– More inflammation than Type 1 Extrinsic– Does not respond well to bronchodilators– Needs treatment with corticosteroids

Page 89: Pulmonary Diseases

Asthma: TypesAsthma: Types

Intrinsic Asthma– Adult > 35– No immunologic cause– Aspirin sensitivity/nasal polyps– Poor bronchodilator response

Page 90: Pulmonary Diseases

Asthma: Signs and SymptomsAsthma: Signs and Symptoms

Onset of attacks associated with “triggers” Dyspnea Non-productive cough Tachypnea Expiratory wheezing Accessory muscle use Retractions

Page 91: Pulmonary Diseases

Asthma: Signs and Symptoms

Absence of wheezing

IMPENDING RESPIRATORY ARREST!

Page 92: Pulmonary Diseases

Asthma: Signs and SymptomsAsthma: Signs and Symptoms

Tachycardia Pulsus paradoxus in severe attacks Anxiety, restlessness (hypoxia) progressing

to drowsiness, confusion (hypercarbia)

Page 93: Pulmonary Diseases

Asthma: Signs and Symptoms

Lethargy, confusion, suprasternal retractions RESPIRATORY FAILURE

Page 94: Pulmonary Diseases

Asthma: Signs and SymptomsAsthma: Signs and Symptoms Early Blood Gas Changes

– Decreased PaO2

– Decreased PaCO2

WHY?

Page 95: Pulmonary Diseases

Asthma: Signs and SymptomsAsthma: Signs and Symptoms

Later Blood Gases– Decreased PaO2

– Normal PaCO2

IMPENDING RESPIRATORY

FAILURE

Page 96: Pulmonary Diseases

Asthma: Signs and SymptomsAsthma: Signs and Symptoms

Still Later Blood Gases– Decreased PaO2

– Increased PaCO2

RESPIRATORY FAILURE

Page 97: Pulmonary Diseases

Asthma: Risk AssessmentAsthma: Risk Assessment Prior ICU admissions Prior intubation >3 ED visits in past year >2 hospital admissions in past year >1 bronchodilator canister used in past month Use of bronchodilators > every 4 hours Chronic use of steroids Progressive symptoms in spite of aggressive Rx

Page 98: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Airway Breathing

– Sitting position or position of comfort

– Humidified O2 by NRB mask

• Dry O2 dries mucus, worsens plugs

– Encourage coughing– Consider intubation, assisted ventilation

• Impending respiratory failure• Avoid if at all possible

Page 99: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Circulation– IV TKO– Assess for dehydration– Titrate fluid administration to severity of

dehydration• Trial bolus of 250 cc

– Monitor ECG, Pulse Oximetry

Page 100: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Obtain medication history Consider

– Overdose– Dysrhythmias

Page 101: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Nebulized Beta-2 agents– Salbutamol

Nebulized anticholinergics– Ipratropium– Atropine

IV Corticosteroid– Methylprednisolone

Combination – Flovent/etc

Page 102: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Rarely used– Questionable efficacy, Potential Complications

– Magnesium Sulfate (IV)– Methylxanthines

• Aminophylline (IV)

Page 103: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Subcutaneous beta agents– Epinephrine 1:1000 q 30 minutes up to 3 doses

• Adult – 0.3 mg SQ/IM• Pediatric – 0.1 to 0.3 mg SQ/IM

POSSIBLE BENEFIT IN PATIENTS WITH VENTILATORY FAILURE

Page 104: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Use EXTREME caution in giving two sympathomimetics or two doses to same patient

Monitor ECG

Page 105: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Avoid– Sedatives

• Depress respiratory drive– Antihistamines

• Decrease LOC, dry secretions– Aspirin

• High incidence of allergy

Page 106: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Continuous Monitoring & Frequent Reassessment

Need for transport? Destination?

Page 107: Pulmonary Diseases

Asthma: ManagementAsthma: Management

Transport Considerations– How severe is the episode?– Is the patient improving?– How extensive (invasive) were the required

therapies?– What does he/she normally do after treatment?– Medical Control or PMD consult

Page 108: Pulmonary Diseases

Drug Delivery Methods: ReviewDrug Delivery Methods: Review

MDI vs. MDI w/ spacer vs. SVNvs. SQ injection

Page 109: Pulmonary Diseases

Status Asthmaticus

Asthma unresponsive to beta-2 adrenergic agents

Page 110: Pulmonary Diseases

Status AsthmaticusStatus Asthmaticus Oxygen (humidified if possible) Nebulized beta-2 agents Nebulized Ipratropium Corticosteroids IV or SQ terbutaline or epinephrine Aminophylline (controversial) Magnesium sulfate (controversial) Intubation

– Caution with PPV

Page 111: Pulmonary Diseases

Golden RuleGolden Rule

Pulmonary edema Pulmonary embolism Allergic reactions COPD Pneumonia Foreign body aspiration Cystic fibrosis

ALL THAT WHEEZES IS NOT ASTHMA

Page 112: Pulmonary Diseases

Lower Airway Disease

Cystic Fibrosis

Page 113: Pulmonary Diseases

Cystic Fibrosis: DefinitionCystic Fibrosis: Definition

Inherited metabolic disease of exocrine glands and sweat glands

Primarily affects digestive, respiratory systems

Begins in infancy

Page 114: Pulmonary Diseases

Cystic Fibrosis: EtiologyCystic Fibrosis: Etiology

Autosomal recessive gene Both parents must be carriers Incidence

– Caucasians--1:2000– Blacks--1:17,000– Asians--very rare

Page 115: Pulmonary Diseases

Cystic Fibrosis: PathophysiologyCystic Fibrosis: Pathophysiology

Obstruction of pancreatic, intestinal gland, bile ducts

Over-secretion by airway mucus glands– mucous plugs

Excess loss of sodium chloride in sweat

Page 116: Pulmonary Diseases

Lower Airway Disease

Neoplasms of the Lung

Page 117: Pulmonary Diseases

Hyperventilation Syndrome

Page 118: Pulmonary Diseases

Hyperventilation SyndromeHyperventilation Syndrome

Brady Textbook Correction, Vol. 3, p. 57– Table 1-4: These are NOT Causes of

hyperventilation syndrome A diagnosis of EXCLUSION!!! An increased ventilatory rate that

– DOES NOT have a pathologic origin– Results from anxiety

Remains a real problem for the patient

Page 119: Pulmonary Diseases

Hyperventilation Syndrome: PathophysiologyHyperventilation Syndrome: Pathophysiology

Tachypnea or hyperpnea secondary to anxiety

Decreased PaCO2

Respiratory alkalosis

Vasoconstriction Hypocalcemia Decreased O2 Release to

Tissues

Page 120: Pulmonary Diseases

Hyperventilation Syndrome:Signs & SymptomsHyperventilation Syndrome:Signs & Symptoms Symptoms

– Light-headedness, giddiness, anxiety– Numbness, paresthesias of:

• Hands• Feet• Circumoral area

– Cold hands, feet– Carpopedal spasms– Dyspnea– Chest pain

Page 121: Pulmonary Diseases

Hyperventilation Syndrome:Signs & SymptomsHyperventilation Syndrome:Signs & Symptoms Signs

– Rapid breathing– Cool & possibly pale skin– Carpopedal spasm– Dysrhythmias

• Sinus Tachycardia• SVT• Sinus arrhythmia

– Loss of consciousness and seizures (late & rare)

Page 122: Pulmonary Diseases

Hyperventilation Syndrome: ManagementHyperventilation Syndrome: Management Educate patient & family

– Consider possible psychopathology especially in “repeat customers”

Transport occasionally required– If loss of consciousness, carpopedal spasm,

muscle twitching, or seizures occur:• Monitor EKG• IV TKO• Transport

Page 123: Pulmonary Diseases

Hyperventilation Syndrome

Hyperventilation itself can be serious

Serious diseases can mimic hyperventilation

Page 124: Pulmonary Diseases

Pulmonary Infectious Diseases

Page 125: Pulmonary Diseases

Laryngotracheobronchitis (Croup)Laryngotracheobronchitis (Croup)

Common syndrome of infectious upper airway obstruction

Viral infection– parainfluenza virus

Subglottic Edema– larynx, trachea,

mainstem bronchi

Usually 3 months to 4 years of age

Page 126: Pulmonary Diseases

Croup: Signs & SymptomsCroup: Signs & Symptoms

Gradual onset (several days)– Often begins with Sx of URI– May begin with only low grade fever

Hoarseness Cough

– “Seal Bark Cough”– “Brassy Cough”

Nocturnal episodes of increased dyspnea and stridor

Page 127: Pulmonary Diseases

Croup: Signs & SymptomsCroup: Signs & Symptoms

Evidence of respiratory distress– Tracheal tugging– Substernal/intercostal retractions– Accessory muscle use

Inspiratory stridor or respiratory distress may develop slowly or acutely

Page 128: Pulmonary Diseases

Croup: ManagementCroup: Management

Usually requires little out of home treatment

Calm & Prevent agitation!!! Moist cool air - mist Humidified O2 by mask or blowby Do Not Examine Upper Airways!!!

Page 129: Pulmonary Diseases

Croup: ManagementCroup: Management

If in respiratory distress:– Racemic epinephrine via nebulizer

• Decreases subglottic edema (temporarily)• Necessitates transport for observation for rebound

– IV TKO - ONLY if severe respiratory distress– Transport

Page 130: Pulmonary Diseases

EpiglottitisEpiglottitis

Bacterial infection (Hemophilus influenza )

Edema of epiglottis (supraglottic)– partial upper airway

obstruction Typically affects 3-7

year olds

Page 131: Pulmonary Diseases

Epiglottitis: PresentationEpiglottitis: Presentation Age: 3-7 years of age

– can occur in adults– can occur in infants

Rapid onset & progression– Fever– Severe sore throat– Dysphagia– Muffled voice– Drooling

Page 132: Pulmonary Diseases

Epiglottitis: PresentationEpiglottitis: Presentation Respiratory difficulty

– Stridor– Usually in an upright, sitting, tripod position

Child may go to bed asymptomatic and awaken during the night with– sore throat– painful swallowing– respiratory difficulty

Page 133: Pulmonary Diseases

Epiglottitis: ManagementEpiglottitis: Management

Do NOT attempt to visualize airway Allow child to assume position of comfort

– AVOID agitation of the child!!!– AVOID anxiety of the healthcare providers!!!

O2 by high concentration mask

Immediate life threat (8-12% die from airway obstruction)

Page 134: Pulmonary Diseases

Epiglottitis: ManagementEpiglottitis: Management

If respiratory failure is eminent:– IV TKO ONLY if eminent or respiratory arrest– Be prepared to take control of airway

• Intubation equipment with smaller sized tubes• Needle cricothyrotomy & jet ventilation equipment

Rapid but calm transport– Appropriate facility

Page 135: Pulmonary Diseases

Upper Respiratory InfectionUpper Respiratory Infection

Common illness Rarely life-threatening Often exacerbates underlying pulmonary

conditions May become more significant in some

patients– Immunosuppressed– Elderly– Chronic pulmonary disease

Page 136: Pulmonary Diseases

Upper Respiratory InfectionUpper Respiratory Infection

Prevention– Avoidance is nearly impossible

• Too many potential causes• Temporarily impaired immune system

– Best prevention strategy is handwashing• Covering of mouth during sneezing and coughing also

helpful

Page 137: Pulmonary Diseases

Pathophysiology of URIPathophysiology of URI

Wide variety of bacteria and viruses are causes– Normal immune system response results in

presentation 20-30% are Group A streptococci Most are self-limiting diseases

Page 138: Pulmonary Diseases

Presentation of URIPresentation of URI

Symptoms– Sore throat– Fever– Chills– HA

Signs– Cervical adenopathy– Erythematous pharynx– Positive throat culture (bacterial)

Page 139: Pulmonary Diseases

Management of URIManagement of URI

Usually requires no intervention Oxygen if underlying condition has been

exacerbated Rarely, pharmacologic interventions are

required– Bronchodilators– Corticosteroid

Occasionally, transport required– Key question: Destination?

Page 140: Pulmonary Diseases

Central Respiratory DepressionCentral Respiratory Depression

Page 141: Pulmonary Diseases

Respiratory Depression: CausesRespiratory Depression: Causes

Head trauma CVA Depressant drug toxicity

– Narcotics– Barbiturates– Benzodiazepines– ETOH

Page 142: Pulmonary Diseases

Respiratory Depression: RecognitionRespiratory Depression: Recognition

Decreased respiratory rate (< 12/min) Decreased tidal volume Decreased LOC

Look, Listen, Feel

Use Your Stethoscope

If you can’t tell whether a patient is breathing

adequately...

THEY PROBABLY

AREN’T

Page 143: Pulmonary Diseases

Respiratory Depression: ManagementRespiratory Depression: Management

Airway– Open, clear, maintain– Consider endotracheal intubation

The need to VENTILATE is not the same as the need to INTUBATE

Page 144: Pulmonary Diseases

Respiratory Depression: ManagementRespiratory Depression: Management

Breathing– Oxygenate, ventilate– Restore normal rate, tidal volume

Oxygen alone is INSUFFICIENT if Ventilation is INADEQUATE

Page 145: Pulmonary Diseases

Respiratory Depression: ManagementRespiratory Depression: Management Circulation

– Obtain vascular access– Monitor EKG (Silent MI may present as CVA)

Manage Cause– Check Blood Sugar– Consider Narcan 2mg IV push if S/S suggest

narcotic overdose Intubate if can not find or treat cause

Page 146: Pulmonary Diseases

Guillian-Barre´ SyndromeGuillian-Barre´ Syndrome

Autoimmune disease– Leads to inflammation and degeneration of

sensory and motor nerve roots (de-myelination)

Progressive ascending paralysis– Progressive tingling and weakness– Moves from extremities then proximally– May lead to respiratory paralysis (25%)

Page 147: Pulmonary Diseases

Guillian-Barre´ Syndrome ManagementGuillian-Barre´ Syndrome Management Treatment based on severity of symptoms

– Control airway– Support ventilation– Oxygen– Transport in cases of respiratory depression,

distress or arrest

Page 148: Pulmonary Diseases

Myasthenia GravisMyasthenia Gravis

Autoimmune disease Causes loss of ACh receptors at

neuromuscular junction– Attacks the ACh transport mechanism at the

NMJ Episodes of extreme skeletal muscle

weakness Can cause loss of control of airway,

respiratory paralysis

Page 149: Pulmonary Diseases

Myasthenia Gravis PresentationMyasthenia Gravis Presentation

Gradual onset of muscle weakness– Face and throat– Extreme muscle weakness

Respiratory weakness -> paralysis Inability to process mucus

Page 150: Pulmonary Diseases

Myasthenia Gravis ManagementMyasthenia Gravis Management

Treat symptomatically Watch for aspiration May require assisted ventilations Assess for Pulmonary infection Transport based upon severity of

presentation

Page 151: Pulmonary Diseases

Case Studies

Page 152: Pulmonary Diseases

Case OneCase One

It is 1430 hrs. You are called to a business for a “possible stroke.” The patient is a 20-year-old female complaining of dizziness and of numbness around her mouth and fingertips.

What would you like to include in your initial differential diagnosis?

Page 153: Pulmonary Diseases

Case OneCase One

Initial Assessment– Airway: Open, maintained by patient– Breathing: Rapid, deep, regular; no accessory

muscle use or retractions– Circulation: Radial pulses present, rapid, full; Skin

warm, dry; capillary refill < 2 seconds– Disability: Awake, alert, anxious

What therapies, if any, would you like to begin?

Page 154: Pulmonary Diseases

Case OneCase One Vital Signs

– P: 126 strong, regular– R: 26 deep, regular– BP: 130/82

Physical Exam– Chest: BS present, equal bilaterally; no

adventitious sounds– Extremities: Equal movement in all

extremities; no weakness; hands cool– Oxygen saturation: 98%

Would you like to make any Changes to your therapies or Diff Dx?

Page 155: Pulmonary Diseases

Case OneCase One

History– Allergies: NKA– Medications: Birth control pills– Past History: No significant past history; no

history of smoking– Last Meal: Lunch 2 hours ago– Events: S/S began suddenly after argument

with supervisor

Page 156: Pulmonary Diseases

Case OneCase One

What problem do you now suspect? How would you manage this patient?

Page 157: Pulmonary Diseases

Case TwoCase Two

It is 0530 hours. You are called to a residence to see a child with “a very high fever and difficulty breathing.” The patient is a 6-old-female. Mother says the child woke up crying about 2 hours ago.

What would you like to include in your differential diagnosis?

Page 158: Pulmonary Diseases

Case TwoCase Two Initial Assessment

– Airway: Inspiratory stridor audible– Breathing: Rapid, shallow, labored– Circulation: Radial pulses present, rapid, weak;

skin pale, hot, diaphoretic; capillary refill is 2 seconds

– Disability: Awake, alert, obviously frightened and in acute distress

What therapies, if any, would you like to begin now?

Page 159: Pulmonary Diseases

Case TwoCase Two Vital Signs

– P: 130 weak, regular– R: 32 shallow, regular with stridor– BP: 110/70

Physical Exam– HEENT: Flaring of nostrils; accessory muscle

use on inspiration; drooling present– Chest: BS present, equal bilaterally; no

adventitious sounds– Oxygen saturation: 92%

Would you like to make any Changes to your therapies or Diff Dx?

Page 160: Pulmonary Diseases

Case TwoCase Two History

– Allergies: NKA– Medications: None– Past History: No significant past history– Last Meal: Dinner at about 1800 hours– Events: Awakened with severe sore throat. Has

experienced increasing difficulty breathing. Will not eat or drink. Says it hurts to swallow

Page 161: Pulmonary Diseases

Case TwoCase Two

What problem do you now suspect? How would you manage this patient?

Page 162: Pulmonary Diseases

Case ThreeCase Three

At 2330 hrs you are called to a residence to see a child with “difficulty breathing.” The patient is a 3 year old male.

How narrow a Differential Diagnosis can you compile at this point?

Page 163: Pulmonary Diseases

Case ThreeCase Three Initial Assessment

– Airway: Open, maintained by patient, mild stridor audible

– Breathing: Rapid, shallow, labored– Circulation: Radial pulses present, weak, regular;

Skin pale, warm, moist; Capillary refill <2 seconds– Disability: Awake, sitting up in bed, looks tired and

miserable

Page 164: Pulmonary Diseases

Case ThreeCase Three Vital Signs

– P: 100 weak, regular– R: 30 shallow, labored with stridor– BP: 90/50

Physical Exam– HEENT: Use of accessory muscles present; no

drooling– Chest: BS present, equal bilaterally with no

adventitious sounds. Auscultation difficult because of stridor and barking cough

Now you can narrow your Diff Dx? To what?

Page 165: Pulmonary Diseases

Case ThreeCase Three History

– Allergies: NKA– Medication: Tylenol for fever before bedtime– Past history: No significant past history– Last meal: Dinner around 1800 hours– Events: Patient has had “cold” for about 3 days.

Reasonably well during day. Awakens around midnight with high-pitched cough that sounds like a dog barking

Page 166: Pulmonary Diseases

Case ThreeCase Three

What problem do you suspect? How would you manage this patient?

Page 167: Pulmonary Diseases

Case FourCase Four At 1945 hours you are dispatched to a

“breathing difficulty” at Long John Silver’s. The patient is a 26-year-old female complaining of strange feeling in her mouth and difficulty swallowing.

What is your differential diagnosis?

Page 168: Pulmonary Diseases

Case FourCase Four

Initial Assessment– Airway: Open, maintained by patient, difficulty

swallowing, voice is hoarse– Breathing: Rapid, labored– Circulation: Radial pulses present, strong, regular;

Skin “flushed”; Capillary refill < 2 seconds– Disability: Awake, alert, very anxious

Page 169: Pulmonary Diseases

Case FourCase Four Vital Signs

– P: 120 strong, regular– R: 26 regular, slightly labored– BP: 118/90

Physical Exam– HEENT: Puffiness around eyes; Lips appear swollen;

Mild accessory muscle use– Chest: BS present, equal bilaterally; No adventitious

sounds– Urticaria on upper chest, extremities– Oxygen saturation: 94%

What therapies do you want to initiate?

Page 170: Pulmonary Diseases

Case FourCase Four History

– Allergies: No drug allergies; Has experienced itching previously when eating shrimp

– Medications: None– Past history: No significant past history; no

history of smoking– Last meal: In progress at time of call– Events: Began to experience itching and

difficulty swallowing after eating “fish and chips”

Page 171: Pulmonary Diseases

Case FourCase Four

What problem do you suspect? How would you manage this patient?

The patient begins to have increased difficulty swallowing, increased anxiety, and increased

difficulty breathing. What do you want to do now?

Page 172: Pulmonary Diseases

Case FiveCase Five At 0130 you are dispatched to an

“unconscious person--police on location.” The patient is a 27-year-old male who is apparently unconscious. The police report they found him lying in an alleyway while they were on routine patrol. He is known to live “on the streets”.

Page 173: Pulmonary Diseases

Case FiveCase Five Initial Assessment

– Airway: Controllable with manual positioning– Breathing: Very slow, shallow– Circulation: Radial pulses present, weak; Skin

pale, cool, moist; Capillary refill 3 seconds– Disability: Unconscious, unresponsive to painful

stimuli

What therapies would you like to begin?

Page 174: Pulmonary Diseases

Case FiveCase Five Vital Signs

– P: 70 regular, weak– R: 4 shallow, regular; alcohol odor on breath– BP: 100/70

Physical Exam– HEENT: Pupils pinpoint, non-reactive– Chest: BS present, equal bilaterally– Abdomen: Soft, non-tender– Extremities: Needle tracks present– Blood glucose: 40 mg/dl

Page 175: Pulmonary Diseases

Case FiveCase Five

What problem or problems do you suspect?

How would you manage this patient?